News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Ustekinumab biosimilar SB17 boasts similar efficacy, safety in psoriasis
10 Sep 2024
byStephen Padilla
SB17, a proposed ustekinumab (UST) biosimilar, demonstrates comparable efficacy, safety, and pharmacokinetics (PK) to the reference drug, as well as lower immunogenicity up to week 28, among individuals suffering from moderate-to-severe psoriasis, according to a study.
10 Sep 2024

Vitamin D deficiency tied to higher T2D risk
09 Sep 2024
Increased serum concentration of 25(OH)D appears to contribute to a reduced risk of type 2 diabetes (T2D) across the glycaemic spectrum below the threshold for diabetes, reports a study. Improving the lipid profile may be partly responsible for the favourable association.
09 Sep 2024

Conservative excisional margin for small MIS tied to low recurrence
09 Sep 2024
byAudrey Abella
For small-sized melanoma in situ (MIS; <10 mm) on low-risk body sites, wide local excision (WLE) using a 5-mm margin was associated with a low rate of recurrence, a retrospective case series study has shown.
09 Sep 2024





